Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.

NCT01101776

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +8 more
Locations
  • Merck Serono Research Site Bruce, Australian Capital Territory, Australia
  • Merck Serono Research Site Burwood, New South Wales, Australia
  • Merck Serono Research Site Chatswood, New South Wales, Australia
  • Merck Serono Research Site Orange, New South Wales, Australia
View all 16 locations
View Trial Details
Completed

Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)

NCT01534182

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Arkhangelsk, Russia
  • Novartis Investigative Site Barnaul, Russia
  • Novartis Investigative Site Belgorod, Russia
  • Novartis Investigative Site Kazan', Russia
View all 26 locations
View Trial Details

Related conditions